New Vernon Capital Holdings II’s Collegium Pharmaceutical COLL Stock Holding History

New Vernon Capital Holdings II’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$177K	Hold	5,343	–	–	0.13%	50
2025 Q4	$247K	Hold	5,343	–	–	0.12%	47
2025 Q3	$187K	Buy	+5,343	New	+$186K	0.09%	57
2024 Q4	–	Sell	-3,400	Closed	-$131K	–	67
2024 Q3	$131K	Hold	3,400	–	–	0.07%	61
2024 Q2	$109K	Hold	3,400	–	–	0.06%	58
2024 Q1	$132K	Buy	+3,400	New	+$119K	0.07%	61

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

New Vernon Capital Holdings II's COLL Position: Q1 2026 in Review

New Vernon Capital Holdings II held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 5,343 shares worth $177K. The position accounts for 0.13% of the portfolio, ranked #50.

New Vernon Capital Holdings II first reported a position in COLL in Q1 2024 and has held it in 6 quarters since. The position peaked at $247K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

New Vernon Capital Holdings II held 5,343 shares of Collegium Pharmaceutical worth $177K as of Q1 2026.
New Vernon Capital Holdings II left its Collegium Pharmaceutical share count unchanged in Q1 2026.
Collegium Pharmaceutical made up 0.13% of New Vernon Capital Holdings II's portfolio in Q1 2026, its #50 holding.
New Vernon Capital Holdings II first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 6 quarters since.
New Vernon Capital Holdings II's Collegium Pharmaceutical position peaked at $247K in Q4 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2026, filed 15 May 2026.